Cargando…
Translational progress on tumor biomarkers
There is an urgent need to apply basic research achievements to the clinic. In particular, mechanistic studies should be developed by bench researchers, depending upon clinical demands, in order to improve the survival and quality of life of cancer patients. To date, translational medicine has been...
Autores principales: | Guo, Hongwei, Zhou, Xiaolin, Lu, Yi, Xie, Liye, Chen, Qian, Keller, Evan T, Liu, Qian, Zhou, Qinghua, Zhang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632916/ https://www.ncbi.nlm.nih.gov/pubmed/26557902 http://dx.doi.org/10.1111/1759-7714.12294 |
Ejemplares similares
-
Translation of genomics and epigenomics in prostate cancer: progress and promising directions
por: Liu, Wennuan, et al.
Publicado: (2016) -
The translational importance of establishing biomarkers of human spinal cord injury
por: Elizei, Sanam Salimi, et al.
Publicado: (2017) -
Mutant p53 in cancer therapy—the barrier or the path
por: Zhou, Xiang, et al.
Publicado: (2018) -
Improving intermittent androgen deprivation therapy: lessons learned from basic and translational research
por: Parikh, Rahul A, et al.
Publicado: (2014) -
Recent progress and perspectives on prostate cancer biomarkers
por: Hatakeyama, Shingo, et al.
Publicado: (2016)